Match Document Document Title
US20050214362 Appetite suppressant  
A method of suppressing appetite is disclosed. An amount of wheat bran sufficient to suppress appetite is consumed prior to or with a meal to achieve satiety and desirable weight reduction....
US20080026050 SOLID DOSE FORMULATIONS OF A THROMBIN RECEPTOR ANTAGONIST  
Capsule formulations of a thrombin receptor antagonist for oral administration are disclosed. In some embodiments, the thrombin receptor antagonist is COMPOUND 1: or a pharmaceutically acceptable...
US20110200668 PHARMACEUTICAL COMPOSITION FOR PREVENTING DYSBIOSIS ASSOCIATED WITH ENTERAL ADMINISTRATION OF ANTIBIOTICS  
In the first variant, the pharmaceutical composition comprises antibiotic and prebiotic in the form of oligosaccharide of a group comprising fructooligosaccharides, galactooligosaccharides,...
US20120308650 MODIFIED ALGINATES FOR CELL ENCAPSULATION AND CELL THERAPY  
Covalently modified alginate polymers, possessing enhanced biocompatibility and tailored physiochemical properties, as well as methods of making and use thereof, are disclosed herein. The...
US20140341982 Vaccination With Immuno-Isolated Cells Producing An Immunomodulator  
The present invention relates to immuno-protected encapsulated cells producing an immunomodulator, for example GM-CSF (granulocyte-macrophage colony stimulating factor). The cells of the invention...
US20150238435 Oral Drug Devices and Drug Formulations  
Compositions containing a drug to be delivered and at least one chemical permeation enhancer (CPE), and methods of making and using these compositions are described herein. In a preferred...
US20120045504 ORAL DRUG DEVICES AND DRUG FORMULATIONS  
Compositions containing a drug to be delivered and at least one chemical permeation enhancer (CPE), and methods of making and using these compositions are described herein. In a preferred...
US20130216483 DELIVERY SYSTEM FOR REMOTE TREATMENT OF AN ANIMAL  
A method of remotely treating an animal including launching a delivery system at the animal, wherein the delivery system comprises a dosage projectile adapted to deliver a biologically active...
US20140056975 Pharmaceutical Composition  
Provided herein is a pharmaceutical composition comprising an antagonist, an agonist, a seal coat, and a sequestering polymer, wherein the antagonist, agonist, seal coat and at least one...
US20140037721 Pharmaceutical Composition  
Provided herein are pharmaceutical compositions comprising an antagonist, an agonist, a seal coat, and a sequestering polymer, wherein the antagonist, agonist, seal coat and at least one...
US20060153908 Spherical pellet formulations  
A process for preparing spherical pellets comprising (a) a water-soluble active ingredient soluble, freely soluble or very soluble in water; and in particular having a water-solubility of ≧0.5...
US20080020018 Combination Products  
A pharmaceutical formulation comprises a plurality of seamless minicapsules having a diameter of from 0.5 mm to 5 mm, at least some of the minicapsules containing a methyxanthine as one active...
US20070065500 Northern white kidney bean extract and red kidney bean extract in combination with green tea extract in the treatment of obesity  
The present invention is for composition containing extract of Northern White Kidney Bean (Phaseolus vulgaris), extract of Red Kidney Bean (Locust Bean Gum) (Ceratonia siliqua) and extract of...
US20120148669 METHOD FOR PREPARING FUNCTIONALIZED LIPID CAPSULES  
The present invention relates to a liquid lipid core/solid lipid shell capsule surface-functionalized with at least one compound containing at least one amino function, characterized in that the...
US20130337027 Medical Devices and Implements with Liquid-Impregnated Surfaces  
Described herein are medical devices and medical implements with high lubricity to flesh (or biological fluid) and/or inhibited nucleation on its surface. The device has a surface comprising an...
US20150071997 Microgels for Encapsulation of Cells and Other Biologic Agents  
Methods of encapsulating cargo in a microgel droplet, microgel droplets prepared according the provided methods, and methods of use thereof are disclosed. The methods of preparing...
US20060105033 Dietary composition containing conjugated linoleic acid and calcium for improved health  
The invention provides a composition for oral administration comprising a mixture of conjugated linoleic acid (CLA), docosahexaenoic acid “DHA”, vitamin E, vitamin C, vitamin B6, vitamin B12,...
US20120301543 SUPPOSITORY COMPRISING PANTOPRAZOLE  
The present invention concerns the field of pharmaceutical technology and relates to a suppository for rectal administration comprising at least one pellet, in particular, a pellet comprising the...
US20120121676 METHOD FOR MANUFACTURING CAPSULES, RESULTING CAPSULES, AND USE OF SAID CAPSULES  
The invention relates to a one-step process for manufacturing capsules from 1 to 100 microns with a polydispersity index of less than 10%, to suspensions of capsules obtained via this process, and...
US20130045273 METHODS FOR USING NUTRITIONAL SUPPLEMENTS CONTAINING LIPOIC ACIDS AND SULFUR CONTAINING COMPOUNDS  
Methods for using nutritional supplements containing lipoic acids and sulfur containing compounds to maintain or increase the levels of cellular GSH in the body are described. In some instances,...
US20140004182 METHODS FOR THE TREATMENT OF SARCOIDOSIS  
Provided herein are methods of treating, preventing and/or managing sarcoidosis by the administration of...
US20070298095 Surface-Modified and Solubility-Improved Hard Capsule  
A hard capsule comprising a water-soluble cellulose derivative as a base material, characterized in that the water-soluble cellulose derivative is formulated with one or two or more compound(s)...
US20080113019 COMPOSITION FOR CAPSULE COATING  
The present invention provides a composition that is suitable for producing a plant-derived, practical capsule shell sheet having both sufficient strength and elongation as a capsule shell,...
US20070172521 Levetiracetam formulations and methods for their manufacture  
Substantially glidant free levetiracetam compositions, pharmaceutical compositions incorporating substantially glidant free levetiracetam compositions, and methods of preparing such compositions...
US20050220865 Compressed composition comprising magnesium salt  
An oral solid compress composition comprising a magnesium salt is provided. The composition provides a rapid dissolution of the magnesium salt, wherein not less than 75% of the magnesium salt...
US20050123602 Rifalazil formulations  
The invention features pharmaceutical compositions including rifalazil and a micelle-forming excipient and methods of use thereof.
US20110020236 METHOD FOR THE SYNTHESIS OF HOLLOW SPHERES  
The present invention relates to a method of synthesizing acoustically active biodegradable hollow spheres with a size below 1 micron. By using water soluble organic solvents and pegylated...
US20090148512 NOVEL USES OF CHLORAMPHENICOL AND ANALOGOUS THEREOF  
A method for reducing the resistance of an MRSA bacterium to an antibiotic selected from the group consisting of vancomycin and methicillin comprising administering to a patient in need thereof an...
US20150140083 Pharmaceutical Formulation Containing Gelling Agent  
Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically...
US20130209556 DPA-ENRICHED COMPOSITIONS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS IN FREE ACID FORM  
DPA-enriched pharmaceutical compositions of polyunsaturated fatty acids in free acid form, therapeutic methods for their use, and processes for refining the compositions from fish oil are presented.
US20120039999 PHARMACEUTICAL COMPOSITIONS OF METABOTROPIC GLUTAMATE 5 RECEPTOR (MGLU5) ANTAGONISTS  
Pharmaceutical compositions of metabotropic glutamate 5 receptor (mGlu5) antagonists or a pharmacologically acceptable salt thereof are disclosed. The compositions contain the therapeutic active...
US20070110799 Film-forming starchy composition  
A film-forming starchy composition for the film-coating of solid forms or the preparation of films. The inventive composition has an amylose content of between 25 and 45%, preferably between 30...
US20100239660 PRODUCT AND USE OF OMEGA-3S MATCHING HUMAN TISSUE RATIOS FOR TREATMENT OF INFLAMMATORY AND OTHER CONDITIONS  
The present invention relates to a product and method for delivering of DHA and EPA in need of omega-3 treatment. It involves administering a liquid formulation such as an oil containing DHA and...
US20060121106 Therapeutic system comprising amoxicillin and clavulanic acid  
The present invention relates to a novel therapeutic system suitable for one or twice daily administration of amoxicillin and clavulanic acid. One part of the dosage is provided by at least one...
US20080131536 Drug for treatment of complications of diabetes mellitus  
The method is used to treat diabetic complications such as neuropathy, peripheral neuritis, cataract and retinopathy have shown improvement with flavonoids present in licorice. The improvement was...
US20100310649 SOLID LIPID MICROCAPSULES CONTAINING GROWTH HORMONE INNER CORE MICROPARTICLES  
The invention relates to growth hormone (GH) formulations having sustained-release properties, in particular human growth hormone (hGH) and methods for their preparation. The growth hormone...
US20100172968 CHIMERIC CANNULAE PROTEINS AND METHODS FOR MAKING AND USING THEM  
A polymer is prepared by self-assembly of a plurality of monomeric polypeptide units. The polymer tends to form a nanotube and is capable of encapsulating a particular drug molecule. Once...
US20110293711 Utilization of Dialkylfumarates  
The present invention relates to the use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune...
US20120237596 NUTRIENT DELIVERY DRUG COMPOSITION  
The present invention is a chemical composition that includes loratidine, a selected one or more of an expeller pressed and a cold pressed oil, a selected one or more of a non-genetically...
US20100239658 GALLIUM NITRATE FORMULATIONS  
The present invention relates to stable pharmaceutical formulations that include a delivery agent and/or pharmaceutically acceptable salt thereof.
US20150030673 CRYSTALLINE FORMS OF 1-(3-TERT-BUTYL-1-P-TOLYL-1H-PYRAZOL-5-YL)-3-(5-FLUORO-2-(1-(2-HYDROXYETHYL)-INDAZOL-5-YLOXY)BENZYL)UREA HYDROCHLORIDE  
Provided herein is a hydrogen chloride salt of 1-(3-/t?r/-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(5-fluoro-2-(1 -(2-hydroxyethyl)-1H-indazol-5-yloxy)benzyl)urea, crystalline forms of...
US20150164927 NATURAL MARINE SOURCE PHOSPHOLIPIDS COMPRISING POLYUNSATURATED FATTY ACIDS AND THEIR APPLICATIONS  
A phospholipid extract from a marine or aquatic biomass possesses therapeutic properties. The phospholipid extract comprises a variety of phospholipids, fatty acid, metals and a novel flavonoid.
US20130202689 NATURAL MARINE SOURCE PHOSPHOLIPIDS COMPRISING POLYUNSATURATED FATTY ACIDS AND THEIR APPLICATIONS  
A phospholipid extract from a marine or aquatic biomass possesses therapeutic properties. The phospholipid extract comprises a variety of phospholipids, fatty acid, metals and a novel flavonoid.
US20070207198 Use Of N-Acety1-D-Glucosamine In The Manufacture Of Medicaments For Anti-Tumors And Anti-Metastasis  
The present invention has disclosed a use of N-acetyl-D-glucosamine in the preparation of a medicament for treating tumors and metastatic diseases. N-acetyl-D-glucosamine is able to regulate...
US20130337056 COATED SOLID PHARMACEUTICAL PREPARATION  
The invention is directed to coated solid pharmaceutical preparations having a very thin coating in the nanometer range and a method for producing such preparations. The coated solid...
US20060159742 Stabilized individually coated ramipril particles, compositions and methods  
The present invention relates to novel ramipril crystalline particles with improved stability and bioavailability. More particularly, the present invention is directed to individually coated,...
US20140205544 Cancer Treatment Comprising Therapeutics That Bind To Phosphatidylserine  
Disclosed is the surprising discovery that aminophospholipids, such as phosphatidylserine and phosphatidylethanolamine, are specific, accessible and stable markers of the luminal surface of tumor...
US20110171281 SOFT CAPSULE COMPOSITION AND METHOD OF USE  
A clear soft vegetarian dosage capsule comprising a first and second biphasic film. The first biphasic film has a plurality of first reservoirs and further comprises a polysaccharide, a seaweed...
US20060110442 Coated sherical seamless filled capsules  
Described is a spherical coated capsule comprising (a) a coating-free capsule having (i) a liquid or viscous core and (ii) a seamless solid shell surrounding this core, and (b) a seamless, solid...
US20150010620 Bulk Enteric Capsule Shells  
The present disclosure relates to aqueous compositions for use in the manufacture of capsule shells endowed with bulk enteric properties. The present disclosure also relates, in part, to aqueous...